Clinical Trial Update: Clinical Trial to Evaluate Two Guidelines for the Administration of Ibuprofen in the Treatment of Persistent Ductus Arteriosus Eco-guided: Impact in the Intestinal Prognosis [Phase 3]

View source ↗

Summary

A Phase 3 clinical trial evaluating two guidelines for ibuprofen administration in treating persistent ductus arteriosus, with an Eco-guided approach and potent…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Persistent Ductus Arteriosus

Drugs mentioned

• Ibuprofen (IBUPROFEN)

Snippet

Sponsor: Instituto de Investigación Hospital Universitario La Paz | Conditions: Persistent Ductus Arteriosus | Phase 3 | Status: UNKNOWN